An apparent danazol-induced primary hepatocellular carcinoma: case report
This case report describes an apparent danazol-induced primary hepatocellular carcinoma in a 49-year-old patient treated continuously for two years with the pituitary gonadotrophin inhibitor, where tumor regression did not occur after drug discontinuation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (5)
- doi:10.1016/s0140-6736(75)91494-4 via openalex
- doi:10.1136/bmj.2.6138.661 via openalex
- doi:10.1136/jcp.32.10.971 via openalex
- doi:10.1111/j.1365-2559.1977.tb01663.x via openalex
- doi:10.1111/j.1365-3083.1978.tb03904.x via openalex
Cited by (10)
- Danazol induced acute icteric cholestatic hepatitis 2007
- Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions 2004
- Danazol-induced hepatocellular carcinoma 2003
- Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report 2002
- [Danazol-induced hepatitis with functional deficit of the C1 inhibitor] 2001
- Danazol therapy: an unusual aetiology of hepatocellular carcinoma 1998
- Danazol for paroxysmal nocturnal hemoglobinuria 1997
- Ultrastructural features of danazol-induced cholestasis: a case study 1996
- Danazol-induced hepatocellular adenoma 1990
- Danazol and cholestatic hepatitis 1986
Source provenance
- openalex
- last seen: 2026-05-13T18:27:55.367740+00:00
- pubmed
- last seen: 2026-10-08T21:15:13.843571+00:00